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Supplemental Figure 1. Evaluation of IRES elements. (A) Schematic of constructs used to evaluate 
panel of IRESs using nanoluciferase (nLUC) as a readout for expression levels (B) IRES-mediated nLUC 
expression in BHK cells 16 hours after transfection of RNA replicons. (C) Total IgG ELISAs of 
supernatants harvested from BHK cells 24 hours after transfection with replicons encoding variations 
of ZIKV-117. EMCV min, Encephalomyocarditis virus minimal sequence; EMCV
opt
, 
Encephalomyocarditis virus full length sequence; EV71, Human enterovirus 71; FGF1,  Fibroblast 
growth factor 1; Arc1, Activity-regulated cytoskeleton-associated protein; VCIP, Vascular endothelial 
growth factor (VEGF) and type 1 collagen inducible protein; C-myc, c-myc proto-oncogene; BIP, 
Immunoglobulin heavy chain binding protein; HCV374, Hepatitis C virus 374 nucleotides; HCV392, 
Hepatitis C virus 392 nucleotides; DHV, Duck hepatitis A virus; CrPv, Cricket paralysis virus 
 
 
Supplemental Figure 2. Evaluation of alternative signal peptides. (A) Schematic of constructs used to 
evaluate alternative signal peptides of the heavy chain (B) Total IgG ELISAs of supernatants harvested 
from BHK cells 24 hours after transfection with replicons encoding variations of ZIKV-117. *p<0.05 as 
determined by one-way ANOVA with Tukey’s multiple comparison test. Data are representative of 3 
independent experiments (C) ZIKV-117 ELISAs of serum harvested 5 days after intramuscular injection 
of each RNA in C57BL/6 mice (n=5/group). Data are representative of 2 independent experiments.  
Supplemental Figure 3. Evaluation of alternative signal peptides. (A) Schematic of constructs used to 
evaluate alternative signal peptides of the heavy chain (B) Total IgG ELISAs of supernatants harvested 
from BHK cells 24 hours after transfection with replicons encoding variations of ZIKV-117. *p<0.05 as 
determined by one-way ANOVA with Tukey’s multiple comparison test. Data are representative of 3 
independent experiments (C) ZIKV-117 ELISAs of serum harvested 5 days after intramuscular injection 
of each RNA in C57BL/6 mice (n=5/group). Data are representative of 2 independent experiments.  
Supplemental Figure 4. Titration of dose concentration for optimal antibody expression following 
intramuscular administration of NLC-formulated replicon RNA. C57BL/6 mice (n=3/group) were 
injected intramuscularly with a range of RNA concentrations in a 50 μL volume such that each group 
received between 0 and 25 μg of RNA. ZIKV-117 concentration then was measured by ELISA of sera 
harvested 5 days after injection. *p<0.05 as determined by one-way ANOVA with Tukey’s multiple 
comparison test. A subset of groups were repeated at n=5/group and similar results were observed. 
Supplemental Figure 5. Effect of IFNAR blockade on antibody expression from replicon RNA. 
C57BL/6 mice (n=5/group) were pre-treated with MAR1-5A3 antibody or mock treated with PBS. One 
day later, both groups were injected intramuscularly with 40 μg of ZIKV-117 RNA, and ZIKV-117 
concentration was measured by ELISA of sera harvested 0, 3, 5, and 7 days after RNA injection. 
*p<0.0001 between groups as determined by two-way ANOVA with Bonferroni’s multiple comparison
test.
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